• Older Black adults with acute MI more likely to present with ‘geriatric' phenotype

    12 days ago - By Healio

    Among adults hospitalized with acute MI, Black patients presented with a more “geriatric” phenotype with more functional impairments than white patients despite being younger, researchers reported.
    In an analysis of older adults hospitalized with acute MI, researchers also found that older Black patients had higher rates of 6-month mortality, which were attenuated after inclusion of functional impairments and other conditions associated with aging.
    “In general, however, measures of physical and cognitive functional impairment are rarely included in studies of health disparities,”
    Read more ...

     

  • Hearts from COVID-19-positive donors may be safe for transplantation

    Hearts from COVID-19-positive donors may be safe for transplantation

    12 days ago - By Healio

    CHICAGO - Short-term outcomes in heart transplant recipients who received hearts from people who were COVID-19 positive are “reassuring,” researchers reported at the American Heart Association Scientific Sessions.
    Samuel T. Kim, BA, medical student at the David Geffen School of Medicine at UCLA, and colleagues presented outcomes of the first 110 COVID-19-positive donor heart transplants in the United States.
    “We found that patients receiving hearts from COVID-19-positive donors experienced similar rates of death in the hospital and at 30 days following transplantation,
    Read more ...

     

  • Paxlovid associated with decreased hospitalization among adults with COVID-19

    Paxlovid associated with decreased hospitalization among adults with COVID-19

    12 days ago - By Healio

    New data published in an MMWR report showed that patients with COVID-19 given a prescription for Paxlovid had a lower rate of hospitalization.
    “, an oral antiviral treatment, is authorized for adults with mild-to-moderate COVID-19 who are at increased risk for progression to severe illness,” Melisa M. Shah, MD, epidemic intelligence officer in CDC's National Center for Immunization and Respiratory Diseases, and colleagues wrote. “However, real-world evidence on the benefit of Paxlovid, according to vaccination status, age group, and underlying health
    Read more ...